References
- FDA Data Standards Manual (monographs). Available from: www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/DataStandardsManualmonographs/ucm071666.htm [last accessed 15 Nov 2012]
- FDA Adverse Event Reporting System. Available from: www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm [last accessed 15 Sep 2012]
- Kiliaridis S, Kjellberg H, Wnneberg B, Engstrom C. The relationship between maximal bite force, bite force endurance, and facial morphology during growth. Acta Odontol Scand 1993;51:323–31
- Calderon PS, Kogawa EM, Lauris JRP, Conti PCR. The influence of gender and bruxism on the human maximum bite force. J Appl Oral Sci 2006;14:448–53
- Bonakdarchian M, Askari N, Askar M. The effect of face from on maximal molar bite force with natural dentition. Arch Oral Biol 2009;54:201–4
- Koc D, Dogan A, Bek B. Bite force and influential factors on bite force measurements: a literature review. Eur J Dent 2010;4:223–32
- United States Pharmacopeia 34/National Formulary 29, Suppl. 2 2012. General chapter <1217> Tablet breaking force. 12601 Twinbrook Parkway, Rockville, MD
- Fell JT, Newton JM. Determination of tablet strength by the diametral-compression test. J Pharm Sci 1970;59:688–91
- ASTM Standard D 0790-10. Standard test methods for flexural properties of unreinforced and reinforced plastics and electrical insulating materials. West Conshohocken (PA): ASTM International; 2010
- David ST, Augsburger LL. Flexure test for determination of tablet tensile strength. J Pharm Sci 1974;63:933–6
- Ambros MC, Podczeck F, Podczeck H, Newton JM. The characterization of the mechanical strength of chewable tablets. Pharm Dev Tech 1998;3:509–15
- Amin MC, Fell JT. Tensile strength and bonding in compacts: a comparison of diametral compression and three-point bending for plastically deforming materials. Drug Dev Ind Pharm 2002;28:809–13
- Krajacic A, Tucker IG. Matrix formation in sustained release tablets: possible mechanism of dose dumping. Int J Pharm 2003;251:67–78
- Ritschel WA, Tompson GA. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure. Meth Find Exp Clin Pharmacol 1983;5:511–25
- Gal JY, Fovet Y, Adib-Yadzi M. About a synthetic saliva for in vitro studies. Talanta 2001;53:1103–15